67 results
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
6 May 24
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
development activities and achieve development goals; the Company’s ability to protect its intellectual property; the direct or indirect impact of global
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
; the Company’s ability to fund development activities and achieve development goals into 2025; the Company’s ability to protect its intellectual
8-K
EX-99.2
hkbltd
25 Mar 24
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
4:07pm
8-K
EX-99.1
beszt5lvoycdg
25 Mar 24
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
4:07pm
8-K
EX-99.1
9i4h5zp kgws7
25 Mar 24
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:03pm
8-K
zfywc
8 Jan 24
Regulation FD Disclosure
8:09am
8-K
EX-99.1
mhmxcrra1rdos
8 Jan 24
Regulation FD Disclosure
8:09am
8-K
EX-99.1
jry31l0a 3j7hjupc
1 Dec 23
Regulation FD Disclosure
9:04am
8-K
EX-99.1
r2t6zoyc
7 Nov 23
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
SC TO-I
EX-99
ix0p hv88
2 Nov 23
Issuer tender offer statement
9:01am
8-K
EX-99.1
2hfybxen ap4vhw7
20 Sep 23
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
4:37pm
8-K
EX-99.1
6ggktazebjyic03w
7 Aug 23
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:05am